<?xml version="1.0" encoding="UTF-8"?>
<p>With the introduction of strict physical distancing policies, sweeping changes were implemented to the practice of substance use disorder care. As of March 17, 2020, the Drug Enforcement Administration (DEA) now allows patients to be initiated on buprenorphine through a telemedicine visit, including telephone only.
 <sup>
  <xref rid="R4" ref-type="bibr">4</xref>
 </sup> While this will improve access for many, some of the most vulnerable will not be able to benefit. Many individuals with opioid use disorder have unstable housing and rely on the informal economy to fund necessities, such as a cellphone. Social distancing and shelter in place orders undoubtedly threaten income for these individuals. As jails and prisons face mounting pressures to decarcerate in order to mitigate the inevitable outbreaks of COVID-19,
 <sup>
  <xref rid="R5" ref-type="bibr">5</xref>
 </sup> many of the individuals deemed eligible for release will be those who also suffer from substance use disorders.
 <sup>
  <xref rid="R6" ref-type="bibr">6</xref>
 </sup> These individuals will be released with little notice and without resources, only to return to an unstable community where they will face mounting challenges, including the forces of addiction. Without access to community providers and the safety net of emergency departments,
 <sup>
  <xref rid="R7" ref-type="bibr">7</xref>
 </sup> it is critical that we design innovative methods to reach these most vulnerable of populations.
</p>
